BioNeutral signs 'Stand Still' agreement with DFB

BioNeutral Group, Inc. (OTC Bulletin Board: BONU), a specialty technology-based life science company, today announced it has signed a "Stand Still" agreement with a leading pharmaceutical company, DFB Pharmaceuticals, Inc. (DFB).

The Terms of the Agreement are being held Confidential. H. Paul Dorman, Chairman and CEO of DFB Pharmaceuticals, said "We believe BioNeutral's Ygiene and Ogiene technology may have opportunities in a number of markets, with the hospital, professional human and animal health care market as one of the most promising areas. Confirmation of materials compatibility and lack of product residue with flexible endoscopes will be a requirement for commercial development with any potential partner. This testing is expected to be completed within ninety (90) days. DFB will fund the expense to perform this confirmatory testing."

In partnership with Dr. Norman Miner, founder of MicroChem Laboratory, DFB has developed patented sterilant technology and recently developed a FDA approved, patented high level disinfectant product for the endoscopy market. North American rights to this product have been licensed to the Olympus Corporation, which is considered the gold standard of endoscopes.

Dr. Andy Kielbania, Chief Scientist of BioNeutral Group stated: "This confirmatory testing agreement with DFB Pharmaceuticals validates our commitment to providing a new level of safe antimicrobial effectiveness to the health care facility, professional human and veterinary health care market. We are looking forward to working with Dr. Norman Miner of MicroChem Labs, who is a well-known expert in the field of disinfectants and sterilants."

Source:

BioNeutral Group, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Evident Corporation - Life Sciences. (2019, June 17). BioNeutral signs 'Stand Still' agreement with DFB. News-Medical. Retrieved on July 12, 2024 from https://www.news-medical.net/news/20101122/BioNeutral-signs-Stand-Still-agreement-with-DFB.aspx.

  • MLA

    Evident Corporation - Life Sciences. "BioNeutral signs 'Stand Still' agreement with DFB". News-Medical. 12 July 2024. <https://www.news-medical.net/news/20101122/BioNeutral-signs-Stand-Still-agreement-with-DFB.aspx>.

  • Chicago

    Evident Corporation - Life Sciences. "BioNeutral signs 'Stand Still' agreement with DFB". News-Medical. https://www.news-medical.net/news/20101122/BioNeutral-signs-Stand-Still-agreement-with-DFB.aspx. (accessed July 12, 2024).

  • Harvard

    Evident Corporation - Life Sciences. 2019. BioNeutral signs 'Stand Still' agreement with DFB. News-Medical, viewed 12 July 2024, https://www.news-medical.net/news/20101122/BioNeutral-signs-Stand-Still-agreement-with-DFB.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Olympus Provi™ CM20 wins highest honor in world-renowned design competition